HLA-E and classic Hodgkin lymphoma: These results indicated that the reduction of E*01:01-carriers in the global cohort of cHL patients (irrespective of the EBV status) is attributable to differences in the distribution of HLA-E genotypes in the EBV-positive subgroup.